TY  - JOUR
AU  - Santin, Miguel
AU  - Perez-Recio, Sandra
AU  - Grijota, Maria D
AU  - Anibarro, Luis
AU  - Barcala, Jose M
AU  - De-Souza-Galvao, Maria L
AU  - Gijon, Paloma
AU  - Luque, Rafael
AU  - Sanchez, Francesca
PY  - 2022
DO  - 10.1371/journal.pone.0276387
UR  - http://hdl.handle.net/10668/20436
T2  - PloS one
AB  - Screening for and treatment of latent tuberculosis (TB) in patients with end-stage kidney disease (ESKD) are recommended. However, there is limited evidence on safety and treatment completion in this population. The objective of the study is to...
LA  - en
PB  - Public Library of Science
KW  - Antitubercular Agents
KW  - Isoniazid
KW  - Latent Tuberculosis
KW  - Rifampin
KW  - Adult
KW  - Humans
KW  - Kidney Failure, Chronic
KW  - Prospective Studies
KW  - Randomized Controlled Trials as Topic
KW  - Drug Therapy, Combination
TI  - Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).
TY  - research article
VL  - 17
ER  -